Related Experiment Video
Updated: Apr 18, 2026

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025
Antidepressants may lead to a decrease in niacin and NAD in patients with poor dietary intake.
Margaretha Viljoen1, Annie Swanepoel2, Priyesh Bipath3
1Department of Psychiatry, School of Medicine, Faculty of Health Sciences, University of Pretoria, South Africa.
Niacin (nicotinic acid/nicotinamide) deficiency, exacerbated by antidepressants, may cause neuropsychiatric symptoms. Consider niacin supplementation for patients with poor diets treated with antidepressants.
Area of Science:
- Biochemistry
- Neuroscience
- Nutritional Science
Background:
- Niacin, encompassing nicotinic acid and nicotinamide, is crucial for cellular integrity and energy production, serving as a precursor to NAD and NADP.
- Niacin deficiency can contribute to neuropsychiatric and neurodegenerative disorders, particularly in individuals with poor dietary intake.
- The kynurenine pathway, involving tryptophan metabolism, synthesizes niacin and NAD, influenced by pro-inflammatory cytokines like interferon-gamma.
Purpose of the Study:
- To hypothesize that patients with poor dietary intake treated with antidepressants are at risk of niacin/NAD deficiency.
- To propose considering niacin supplementation in this patient group to prevent associated neuropsychiatric symptoms.
- To suggest ruling out niacin deficiency in treatment-resistant depression cases unresponsive to antidepressants.
Main Methods:
- Literature review and hypothesis formulation based on biochemical pathways and known drug effects.
- Analysis of the interplay between antidepressant anti-inflammatory effects, indoleamine 2,3-dioxygenase (IDO) activity, and niacin synthesis.
- Proposed consideration of niacin supplementation and diagnostic exclusion in specific clinical scenarios.
Main Results:
- Antidepressants may inhibit IDO, potentially reducing niacin and NAD synthesis.
- This reduction, coupled with poor dietary intake, could lead to niacin/NAD deficiency and neuropsychiatric symptoms.
- Subclinical niacin deficiency may mimic or worsen existing psychiatric conditions, complicating diagnosis and treatment.
Conclusions:
- Patients with inadequate diets receiving antidepressants may be at risk for niacin/NAD deficiency.
- Niacin supplementation should be considered in at-risk individuals to prevent deficiency and associated neuropsychiatric issues.
- Niacin deficiency is a potential, easily testable factor in treatment-resistant depression and should be investigated.
Related Concept Videos
Antidepressant Drugs: MAOIs and Other Agents
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
Antidepressant Drugs: Overview
CNS Depressants: Alcohol and Nicotine
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Vitamins

